相似文献
1
Simian immunodeficiency virus macaque models of HIV latency.
Curr Opin HIV AIDS. 2011 Jan;6(1):57-61. doi: 10.1097/COH.0b013e32834086ce.
2
A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system.
Curr Opin HIV AIDS. 2011 Jan;6(1):37-42. doi: 10.1097/COH.0b013e3283412413.
3
Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
mBio. 2017 Aug 15;8(4):e01186-17. doi: 10.1128/mBio.01186-17.
4
A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.
J Virol. 2009 Sep;83(18):9247-57. doi: 10.1128/JVI.00840-09. Epub 2009 Jul 1.
5
Insights into the Impact of CD8 Immune Modulation on Human Immunodeficiency Virus Evolutionary Dynamics in Distinct Anatomical Compartments by Using Simian Immunodeficiency Virus-Infected Macaque Models of AIDS Progression.
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01162-17. Print 2017 Dec 1.
6
Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS.
J Virol. 2010 Mar;84(6):2913-22. doi: 10.1128/JVI.02356-09. Epub 2009 Dec 23.
7
Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model.
AIDS Res Hum Retroviruses. 2006 Jun;22(6):580-8. doi: 10.1089/aid.2006.22.580.
8
Molecular Control of HIV and SIV Latency.
Curr Top Microbiol Immunol. 2018;417:1-22. doi: 10.1007/82_2017_74.
9
Infectious Virus Persists in CD4 T Cells and Macrophages in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques.
J Virol. 2019 Jul 17;93(15). doi: 10.1128/JVI.00065-19. Print 2019 Aug 1.
10
Seminal Simian Immunodeficiency Virus in Chronically Infected Cynomolgus Macaques Is Dominated by Virus Originating from Multiple Genital Organs.
J Virol. 2018 Jun 29;92(14). doi: 10.1128/JVI.00133-18. Print 2018 Jul 15.
引用本文的文献
1
Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV cancer.
Nat Commun. 2023 Oct 21;14(1):6681. doi: 10.1038/s41467-023-41625-8.
2
Opioid abuse and SIV infection in non-human primates.
J Neurovirol. 2023 Aug;29(4):377-388. doi: 10.1007/s13365-023-01153-z. Epub 2023 Jul 7.
3
Psychosocial Stress Alters the Immune Response and Results in Higher Viral Load During Acute Simian Immunodeficiency Virus Infection in a Pigtailed Macaque Model of Human Immunodeficiency Virus.
J Infect Dis. 2021 Dec 15;224(12):2113-2121. doi: 10.1093/infdis/jiab252.
4
Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.
Viruses. 2021 Feb 21;13(2):335. doi: 10.3390/v13020335.
5
HIV latency reversal research and the potential effects on the central nervous system: is concern warranted?
J Int AIDS Soc. 2016 May 9;19(1):21008. doi: 10.7448/IAS.19.1.21008. eCollection 2016.
6
Enhanced antiretroviral therapy in rhesus macaques improves RT-SHIV viral decay kinetics.
Antimicrob Agents Chemother. 2014 Jul;58(7):3927-33. doi: 10.1128/AAC.02522-14. Epub 2014 Apr 28.
7
HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies.
J Leukoc Biol. 2014 Jan;95(1):71-81. doi: 10.1189/jlb.0713368. Epub 2013 Oct 24.
8
Expression of the memory marker CD45RO on helper T cells in macaques.
PLoS One. 2013 Sep 4;8(9):e73969. doi: 10.1371/journal.pone.0073969. eCollection 2013.
9
Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.
Retrovirology. 2013 Feb 1;10:11. doi: 10.1186/1742-4690-10-11.
10
Therapeutic imprinting of the immune system: towards a remission of AIDS in primates?
Retrovirology. 2012 Sep 14;9:75. doi: 10.1186/1742-4690-9-75.
本文引用的文献
1
Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.
PLoS One. 2010 Jul 23;5(7):e11640. doi: 10.1371/journal.pone.0011640.
2
Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques.
Am J Pathol. 2010 Aug;177(2):777-91. doi: 10.2353/ajpath.2010.091248. Epub 2010 Jul 1.
3
Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA.
J Infect Dis. 2010 Jul 1;202(1):161-70. doi: 10.1086/653213.
4
Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS.
PLoS One. 2010 May 7;5(5):e10523. doi: 10.1371/journal.pone.0010523.
5
Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy.
Retrovirology. 2010 Mar 16;7:21. doi: 10.1186/1742-4690-7-21.
6
In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.
PLoS Pathog. 2010 Jan 29;6(1):e1000748. doi: 10.1371/journal.ppat.1000748.
7
CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.
PLoS Pathog. 2010 Jan 29;6(1):e1000747. doi: 10.1371/journal.ppat.1000747.
8
Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS.
J Virol. 2010 Mar;84(6):2913-22. doi: 10.1128/JVI.02356-09. Epub 2009 Dec 23.
9
RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.
AIDS Res Ther. 2009 Nov 5;6:23. doi: 10.1186/1742-6405-6-23.
10
RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy.
Retrovirology. 2009 Nov 4;6:101. doi: 10.1186/1742-4690-6-101.
Zotero 插件